Good news! @WHO recommends new treatment guidelines for #leishmaniasis. East Africa: new combo treatment is 90%+ effective, cuts injections 34→14, hospitalization 60-90→14 days. South Asia: safer PKDL options, less toxic. Read more bit.ly/4x9OYv3 #BeatNTDs @dndi.org

WHO recommends new, better and safer treatment regimens for leishmaniasis

The World Health Organization (WHO) has issued major updates to its leishmaniasis treatment guidelines, introducing a new regimen for visceral leishmaniasis (VL/kala-azar) in eastern Africa and severa...

bit.ly

Join us as we explore advances in research, diagnosis & care for people with #mycetoma. If you haven't registered yet, there's still time to be part of the conversation. 🗓️ Thursday 16 July, 2026 🕒 16:00–17:15 EAT / 1:00–2:15 GMT 🔗 Register here: bit.ly/4gzAD6h #MycetomaAt10 #BeatNTDs

Welcome! You are invited to join a webinar: A decade of mycetoma advocacy and research: Lessons learned and the future. After registering, you will receive a confirmation email about joining the webin...

Join us on Thursday, 16 July 2026, for a webinar marking a decade since the World Health Organization (WHO) recognized mycetoma as a Neglected Tropical Disease (NTD). This event will explore the evolu...

bit.ly

Severe childhood #diarrhoea causes around 500,000 deaths each year, yet no new #antibiotics are being developed specifically for this condition. This study outlines the key characteristics future treatments should have to meet the needs of #children in #LMICs. Read more ➡️ doi.org/10.1093/jaca...

Join us on 16 July, 2026 for a webinar on "A Decade of Mycetoma Advocacy and Research: Lessons Learned and the Future," as we mark 10 years since #mycetoma was recognized as an #NTD by @who.int Register: lnkd.in/ePbEDdPq #BeatNTDs #GlobalHealth #MycetomaAt10

The @gardp_amr 2025 Annual Report highlights the progress that collaboration can achieve in the fight against antimicrobial resistance. It's a timely reminder that sustained investment & partnerships are essential to stay ahead of #AMR. Read more here bit.ly/3SRz2i7

Global Antibiotic R&D Partnership (GARDP)@gardp.bsky.social · last mo.

But the story doesn't stop there. The report also highlights expansion of the GARDP portfolio to tackle drug-resistant infections, the kickoff of the second stage of our neonatal sepsis trial, and efforts to advance antibiotic access and stewardship. #AMR #GlobalHealth #GARDP

It's been 10 years since @who.int recognized #Mycetoma as an #NTD. Join us for a webinar 'A Decade of Mycetoma Advocacy and Research: Lessons Learned and the Future' as we reflect on improving diagnosis, treatment & access. @mycetomarc.bsky.social Registration➡️ bit.ly/4f3kZP3 #MycetomaAt10

Welcome! You are invited to join a webinar: A decade of mycetoma advocacy and research: Lessons learned and the future. After registering, you will receive a confirmation email about joining the webin...

Join us on Thursday, 16 July 2026, for a webinar marking a decade since the World Health Organization (WHO) recognized mycetoma as a Neglected Tropical Disease (NTD). This event will explore the evolu...

bit.ly

A drive for self-reliance in health care stems from a succession of crises that laid bare how dependent the continent’s systems are on foreign support

Ebola has put Africa’s fragile health systems in the spotlight

Emergencies and aid cuts are accelerating a push for self-reliance

econ.st

This week, I attended the #AfricaExCon meeting in Cairo, Egypt, where leaders & partners explored how pooled procurement can strengthen health systems across Africa. Key take away, the strength of a health system is measured by how well it serves remote & underserved communities. @dndi.org

For years, mycetoma left Banchayehu from Ethiopia with a heavily swollen foot, unable to wear shoes or care for her 3 kids. After finding treatment at Boru Meda Hospital, she's reclaimed her life. Her journey reminds us why we advocate for early diagnosis & health equity. #MycetomaAt10 #BeatNTDs

Join @bornanyaoke.bsky.social tomorrow at the annual mycology symposium. She will share insights on R&D for #mycetoma, a devastating #NTD causing severe disabilities. 📅 09 June, 2026 ⏱️ 18:00 EAT / 15:00 GMT 🔗 bit.ly/4ecmEAg or scan the QR code 👇 #HealthEquity #EndNTDs

By breaking down silos and pooling expertise across #NTDs, antibiotic resistance, and malaria, this partnership creates a powerful engine for patient-centered R&D. True health security means ensuring life-saving innovation reaches those in greatest need. #GlobalHealth #HealthEquity

Drugs for Neglected Diseases initiative (DNDi)@dndi.org · 2mo ago

We join forces with @gardp.bsky.social & @mmv.org to accelerate drug development for patients in greatest need! Emma Hannay, Chief Strategy Officer at MMV, explains why this collaboration is especially important in this changing global health ecosystem. 👉Press Release: dndi.org/press-releas...

The Accra Reset is transforming global health. It challenges African nations to reject aid dependency & step up as co-architects of their own health security and local manufacturing. Read more from President John Dramani Mahama’s speech at the #WHA79 bit.ly/4dDSRQX

Full Text: Mahama's address to the 79th World Health Assembly

Keynote Address to the 79th World Health Assembly of the World Health Organisation by H.E. John Dramani Mahama, President of the Republic of Ghana.

bit.ly

On this #ClinicalTrialsDay, we are celebrating a shift toward health equity. By building local research networks & collaborating directly with patients & frontline workers, @dndi.org is developing affordable, adapted life saving treatment. #CTD2026 #HealthEquity #GlobalHealth

The #WHS2026 officially started yesterday in Nairobi with H.E. President William Ruto giving his remarks on the need for increased domestic resourcing & policy leadership on health. "Delivering health is our responsibility as a nation. Any other assistance is secondary," he noted.

What's new in #GlobalHealth R&D? 💊Sleeping sickness drug endorsement 🦠New drug-resistant bacteria approach 🔬Potential superbug treatment www.ghtcoalition.org/blog/researc...

Research Roundup: Sleeping sickness drug endorsement, Potential superbug treatment, New drug-resistant bacteria approach

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

ghtcoalition.org

The 1st single‑dose treatment for sleeping sickness has received a positive opinion from @ema.europa.eu . We are proud to have contributed to its development with @dndi.org & @sanofi - a pill that could transform care & bring us closer to disease elimination. Read more ➡️https://bit.ly/dndi-acozi

The future of African public health must be collaborative, data-driven & above all, people-centred. The recent partnership between @dndi.org & @aphrc.bsky.social will be a gamechanger in strengthening the health ecosystem at large. #HealthEquity Read more🔗 bit.ly/4tynePW

Climate change is moving the goalposts for health. As sandflies & mosquitoes migrate to new regions, our partnerships must move faster. From the lab to the "last mile," we are uniting data + R&D to beat #NTDs in a warming world. Today we #UniteActEliminate to #beatNTDs

Drugs for Neglected Diseases initiative (DNDi)@dndi.org · 6mo ago

📢 Today is #WorldNTDDay! Over 1B people are affected by neglected tropical diseases. Too many still lack safe & effective treatments. 👉 Share this post to support science, innovation & global health funding. #EndTheNeglect #BeatNTDs #UniteActEliminate

Are you at #CPHIA2025? Join us! Innovation is the driving force behind eliminating neglected tropical diseases #NTDs, from faster diagnostics to safer treatments & smarter surveillance tools. @dndi.org 🗓️24 Oct, 2025 ⏲️16:00 -17:30 SAST 📍Meeting Room 12CD, Durban ICC

The annual programme review meeting for visceral ##leishmaniasis in Eastern Africa has started in Kampala, Uganda with @dndi.org and The END Fund. Looking forward to fruitful deliberations on addressing challenges and closing the gaps through partnerships to achieve elimination. #ZeroLeish

We’re excited for @dndi.org to be receiving the Hideyo Noguchi Africa Prize in Japan at #TICAD9 in the medical services category for our work in transforming lives and driving innovation where it’s needed most. #GlobalHealth #EndTheNeglect

🦟3 mosquito species transmit some of the most devastating diseases: aedes, anopheles, culex. Together with partners like @mmv.org, we're working to develop safe, affordable & effective treatments against mosquito-borne diseases. #WorldMosquitoDay www.youtube.com/shorts/NOLiF...

3 Dangerous Mosquitoes

YouTube video by Drugs for Neglected Diseases initiative (DNDi)

youtube.com

🎉Congratulations to Kenya for eliminating rhodesiense #SleepingSickness as a public health problem. 👏A huge win for public health & innovation. We are happy that our work has supported safer, simpler treatments for this disease in Africa. bit.ly/4oiAMw6 #SleepingSicknessFreeKenya

We are proud of Kenya's achievement in eliminating #sleepingsickness as a public health problem, becoming the 10th Nation to eliminate the disease globally. Elimination is not eradication. We look forward to full integration of HAT interventions in healthcare systems. #beatNTDs bit.ly/45NE6XV

Patients like Jennifer silently suffer from #mycetoma, a disease whose global burden is unknown. @dndi.org and partners are working to reduce disease knowledge gaps & bolster international partnerships to establish transnational clinical studies bit.ly/45jOfet #beatNTDs

Celebrating my colleague Dr Monique Wasunna, one of six inspiring African women spotlighted by @ghtcoalition.org. Her leadership in driving transformative trials in #leishmaniasis & #sleepingsickness have contributed to accelerated access to affordable, life-saving treatments. bit.ly/4lIi2Ez

Antimicrobial resistance is on track to cause 70% more deaths by 2050.The solution? Not just new antibiotics, but fair access to them. GARDP is reimagining antibiotic R&D by centering people’s health, not just profits. #ThisIsBig #GlobalHealth bit.ly/4lVCguH

Antimicrobial Resistance: a global crisis we can't ignore

Microbes may be small—but when they become resistant to antibiotics, they cause BIG problems. For over 100 years, antibiotics have protected us: curing infections, enabling life-saving surgeries, and shielding the most vulnerable. But that protection is under threat. Drug-resistant infections are now one of the world’s biggest killers—linked to nearly 5 million deaths each year. Without urgent action, the crisis will escalate, putting lives everywhere at risk. Our campaign video highlights the urgent need to act—before it’s too late. Learn more: https://gardp.org/this-is-big/ 🛑 Drug resistance is not a future threat. It’s happening now. #StopSuperbugs #AMR #AntibioticResistance #GARDP #Superbugs #DrugResistance #PublicHealth

bit.ly

Five patients have been successfully treated for #sleepingsickness using a new all-oral drug, Fexinidazole Winthrop after successful clinical trials by @dndi.org This marks a milestone in the fight against human African trypanosomiasis #NTD spread by tsetse flies. More ➡️ bit.ly/4f7xZln #beatNTDs

About 50% of people with #leishmaniasis are children. Our goal at @dndi.org is to continue implementing safer, shorter treatments with existing drugs while advancing the development of all-new treatments for affected communities. Read more in the annual report👉https://bit.ly/4eT4l3c #EndTheNeglect

"We are working to bridge the knowledge gap on #mycetoma through epidemiological studies in Kenya, Senegal, Ethiopia and India. Lack of investment, research, access to diagnosis and treatment is contributing to the neglect," said @bornanyaoke.bsky.social